A dysregulated inflammatory response, coupled to suppression of the antiviral and anticancer responses of CD8+ T cells and NK cells has emerged as a commonality in the altered immune responses evident in SARS-CoV-2 infection and the tumour microenvironment [1]. The gene discussed is CD8A; the disease is neoplasm.